Methods and compositions related to the next generation vaccine
US-2025277005-A1 · Sep 4, 2025 · US
from Chlamydiales (O)
from Chlamydiales (O) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/295 |
| Official title | from Chlamydiales (O) |
| Display label | from Chlamydiales (O) |
| Total patents | 61 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 9 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 9 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Attenuated maturation-defective chlamydia vaccines
US-2025186573-A1 · Jun 12, 2025 · US
Compositions for use in treatment of Chlamydia
US-12263213-B2 · Apr 1, 2025 · US
Compositions for use in treatment of chlamydia
US-2024299524-A1 · Sep 12, 2024 · US
Compositions and methods for treating and preventing human chlamydial infections and diseases using attenuated animal chlamydia
US-2024156938-A1 · May 16, 2024 · US
Baceriophage virus-like particles vaccines for chlamydia trachomatis infections
US-2024156937-A1 · May 16, 2024 · US
Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells
US-2024131138-A1 · Apr 25, 2024 · US
Chlamydia trachomatis antigenic polypeptides and uses thereof for vaccine purposes
US-2024124532-A1 · Apr 18, 2024 · US
Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
US-2023235339-A1 · Jul 27, 2023 · US
Systems, methods, and compositions for targeted nucleic acid editing
US-11685916-B2 · Jun 27, 2023 · US
Methods and compositions related to the next generation vaccine
US-2023112697-A1 · Apr 13, 2023 · US
Systems, methods, and compositions for targeted nucleic acid editing
US-11618896-B2 · Apr 4, 2023 · US
Targeted gene disruption methods and immunogenic compositions
US-11541108-B2 · Jan 3, 2023 · US
Recombinant expression of chlamydia momp antigen
US-2022378892-A1 · Dec 1, 2022 · US
Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
US-11466279-B2 · Oct 11, 2022 · US
Methods and compositions related to the next generation vaccine
US-11439700-B2 · Sep 13, 2022 · US
Recombinant expression of Chlamydia MOMP antigen
US-11406695-B2 · Aug 9, 2022 · US
Methods and compositions related to the next generation vaccine
US-2021252127-A1 · Aug 19, 2021 · US
Recombinant chlamydia-activated b cell platforms and methods of use thereof
US-2021106668-A1 · Apr 15, 2021 · US
Recombinant expression of chlamydia momp antigen
US-2021093703-A1 · Apr 1, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/295?
- CPC C07K14/295 is the Cooperative Patent Classification code for “from Chlamydiales (O).”
- How many patents are filed under CPC C07K14/295 (from Chlamydiales (O))?
- Our database includes 61 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/295 growing?
- Publication counts under this code: 5 in 2024 vs 4 in 2025 (latest complete years).